China-Universal-Asset-Management-Co

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-04-30
Total Holdings
486
Total Value
1074810188
Accession Number
0001906594-25-000002
Form Type
13F-HR
Manager Name
China-Universal-Asset-Management-Co
Data Enrichment
96% identified
465 identified21 unidentified

Holdings

486 positions • $1.1B total value
Manager:
Search and click to pin securities to the top
Page 24 of 25
PLIANT THERAPEUTICS, INC.
Shares:12.2K
Value:$16.5K
% of Portfolio:0.0% ($16.5K/$1.1B)
28658R106
Shares:13.5K
Value:$16.4K
% of Portfolio:0.0% ($16.4K/$1.1B)
MACROGENICS INC
Shares:12.6K
Value:$16.0K
% of Portfolio:0.0% ($16.0K/$1.1B)
Biomea Fusion, Inc.
Shares:7.3K
Value:$15.5K
% of Portfolio:0.0% ($15.5K/$1.1B)
REPLIGEN CORP
Shares:115
Value:$14.6K
% of Portfolio:0.0% ($14.6K/$1.1B)
Artiva Biotherapeutics, Inc.
Shares:4.9K
Value:$14.6K
% of Portfolio:0.0% ($14.6K/$1.1B)
TScan Therapeutics, Inc.
Shares:9.8K
Value:$13.6K
% of Portfolio:0.0% ($13.6K/$1.1B)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Shares:89
Value:$13.4K
% of Portfolio:0.0% ($13.4K/$1.1B)
GSK plc
Shares:338
Value:$13.2K
% of Portfolio:0.0% ($13.2K/$1.1B)
Acrivon Therapeutics, Inc.
Shares:6.2K
Value:$12.7K
% of Portfolio:0.0% ($12.7K/$1.1B)
Quanterix Corp
Shares:1.9K
Value:$12.3K
% of Portfolio:0.0% ($12.3K/$1.1B)
Inozyme Pharma, Inc.
Shares:12.9K
Value:$11.7K
% of Portfolio:0.0% ($11.7K/$1.1B)
Pyxis Oncology, Inc.
Shares:11.9K
Value:$11.7K
% of Portfolio:0.0% ($11.7K/$1.1B)
ILLUMINA, INC.
Shares:146
Value:$11.6K
% of Portfolio:0.0% ($11.6K/$1.1B)
Applied Therapeutics, Inc.
Shares:23.3K
Value:$11.4K
% of Portfolio:0.0% ($11.4K/$1.1B)
OnKure Therapeutics, Inc.
Shares:2.5K
Value:$10.9K
% of Portfolio:0.0% ($10.9K/$1.1B)
SUTRO BIOPHARMA, INC.
Shares:16.5K
Value:$10.8K
% of Portfolio:0.0% ($10.8K/$1.1B)
92204A702
Shares:19
Value:$10.3K
% of Portfolio:0.0% ($10.3K/$1.1B)
78464A763
Shares:75
Value:$10.2K
% of Portfolio:0.0% ($10.2K/$1.1B)
EXACT SCIENCES CORP
Shares:216
Value:$9.4K
% of Portfolio:0.0% ($9.4K/$1.1B)